ProShare Advisors LLC Reduces Position in UnitedHealth Group Incorporated $UNH

ProShare Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 258,722 shares of the healthcare conglomerate’s stock after selling 20,569 shares during the quarter. ProShare Advisors LLC’s holdings in UnitedHealth Group were worth $89,337,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Linden Thomas Advisory Services LLC grew its holdings in shares of UnitedHealth Group by 2.8% during the third quarter. Linden Thomas Advisory Services LLC now owns 4,836 shares of the healthcare conglomerate’s stock worth $1,670,000 after buying an additional 134 shares during the last quarter. D.B. Root & Company LLC increased its holdings in shares of UnitedHealth Group by 21.0% in the third quarter. D.B. Root & Company LLC now owns 2,050 shares of the healthcare conglomerate’s stock valued at $708,000 after purchasing an additional 356 shares during the period. REAP Financial Group LLC lifted its holdings in shares of UnitedHealth Group by 111.6% during the third quarter. REAP Financial Group LLC now owns 419 shares of the healthcare conglomerate’s stock worth $145,000 after purchasing an additional 221 shares during the period. LexAurum Advisors LLC raised its position in UnitedHealth Group by 13.2% during the 3rd quarter. LexAurum Advisors LLC now owns 10,668 shares of the healthcare conglomerate’s stock worth $3,684,000 after buying an additional 1,242 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 15.2% in the third quarter. Oppenheimer Asset Management Inc. now owns 48,745 shares of the healthcare conglomerate’s stock valued at $16,832,000 after acquiring an additional 6,421 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of UnitedHealth Group in a research report on Wednesday, January 21st. The Goldman Sachs Group initiated coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target on the stock. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. UBS Group reduced their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Finally, Jefferies Financial Group dropped their target price on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Down 0.5%

UNH stock opened at $275.17 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The firm has a market capitalization of $249.26 billion, a PE ratio of 20.86, a P/E/G ratio of 1.27 and a beta of 0.41. The company’s 50 day simple moving average is $324.91 and its 200-day simple moving average is $323.43.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.22 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the prior year, the firm earned $6.81 EPS. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.